Investigación Clínica en Infección VIH, Infección Endovascular y Bacteriemias

References

  • Pulido F, Ribera E, Lagarde M, Pérez-Valero I, Palacios R, Iribarren JA, Payeras A, Domingo P, Sanz J, Cervero M, Curran A, Rodríguez-Gómez FJ, Téllez MJ, Ryan P, Barrufet P, Knobel H, Rivero A, Alejos B, Yllescas M, Arribas JR; DUAL-GESIDA-8014-RIS-EST45 Study Group. Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial. Clin Infect Dis. 2017 Nov 29;65(12):2112-2118. PMID: 29020293.
  • Merchante N, Rivero-Juárez A, Téllez F, Merino D, Ríos-Villegas MJ, Ojeda-Burgos G, Omar M, Macías J, Rivero A, Pérez-Pérez M, Raffo M, López-Montesinos I, Márquez-Solero M, Gómez-Vidal MA, Pineda JA; Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI). Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis. AIDS. 2017 Feb 20;31(4):493-500. PMID: 27922855.
  • Aguilera A, Navarro D, Rodríguez-Frias F, Viciana I, Martínez-Sapiña AM, Rodríguez MJ, Martró E, Lozano MC, Coletta E, Cardeñoso L, Suárez A, Trigo M, Rodríguez-Granjer J, Montiel N, de la Iglesia A, Alados JC, Vegas C, Bernal S, Fernández-Cuenca F, Pena MJ, Reina G, García-Bujalance S, Echevarria MJ, Benítez L, Pérez-Castro S, Ocete D, García-Arata I, Guerrero C, Rodríguez-Iglesias M, Casas P, García F. Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study). J Viral Hepat. 2017 Sep;24(9):725-732. PMID: 28248445.
  • Perez-Molina JA, Rubio R, Rivero A, Pasquau J, Suárez-Lozano I, Riera M, Estébanez M, Palacios R, Sanz-Moreno J, Troya J, Mariño A, Antela A, Navarro J, Esteban H, Moreno S; GeSIDA 7011 Study Group. Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study). J Antimicrob Chemother. 2017 Jan;72(1):246-253. PMID: 27629070.
  • Rivero-Juarez A, Lopez-Cortes LF, Castaño M, Merino D, Marquez M, Mancebo M, Cuenca-Lopez F, Jimenez-Aguilar P, Lopez-Montesinos I, Lopez-Cardenas S, Collado A, Lopez-Ruz MA, Omar M, Tellez F, Perez-Stachowski X, Hernandez-Quero J, Girón-Gonzalez JA, Fernandez-Fuertes E, Rivero A; HERACLES cohort study team of the Grupo de Estudio de Hepatitis Virales (HEPAVIR) of the Sociedad Andaluza de Enfermedades Infecciosas (SAEI). Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy. Eur J Clin Microbiol Infect Dis. 2017 Mar;36(3):487-494. PMID: 27787664.
  • Neukam K, Morano-Amado LE, Rivero-Juárez A, Macías J, Granados R, Romero-Palacios A, Márquez M, Merino D, Ortega E, Alados-Arboledas JC, Cucurull J, Omar M, Ryan-Murua P, Pineda JA; Grupo de Estudio de Hepatitis Vírica, of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica: GEHEP-SEIMC and Grupo de Estudio de Hepatitis Vírica, of the Sociedad Andaluza de Enfermedades Infecciosas y Microbiología Clínica: HEPAVIR/Red de Investigación en SIDA (RIS-HEP07). Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients. Eur J Clin Microbiol Infect Dis. 2017 May;36(5):853-861. PMID: 28004322.
  • Arch Bronconeumol. 2017 Sep;53(9):531-533. PMID: 28063611.
  • Med Clin (Barc). 2017 Oct 23;149(8):331-338. PMID: 28431897.
  • Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Crespo M, Domingo P, Estrada V, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, de la Torre J, Tuset M, Gatell JM. Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults. Enferm Infecc Microbiol Clin. 2017 Feb;35(2):88-99. PMID: 27459919.
  • Kestler M, Muñoz P, Marín M, Goenaga MA, Idígoras Viedma P, de Alarcón A, Lepe JA, Sousa Regueiro D, Bravo-Ferrer JM, Pajarón M, Costas C, García-López MV, Hidalgo-Tenorio C, Moreno M, Bouza E; Spanish Collaboration on Endocarditis (GAMES). Endocarditis caused by anaerobic bacteria. Anaerobe. 2017 Oct;47:33-38. PMID: 28389412.
  • Enferm Infecc Microbiol Clin. 2017 Oct;35(8):493-498. PMID: 27061975.
  • Arboledas JCA, Guerrero IP, Rodríguez MJB, Martos ET, Pérez AB, León CC, Sierra Sánchez JF, Prieto MDL, Porcuna NC, Mochón MDO, Macías J, de la Iglesia Salgado A, Granger JR, Fernández MD, Lozano IG, Ramírez ER, Rivero A, Del Carmen Lozano Domínguez M, Viciana I, Montemayor JCG, García FG. Hepatitis C virus core antigen in the management of patients treated with new direct-acting antivirals. Diagn Microbiol Infect Dis. 2017 Sep;89(1):29-34. PMID: 28669680.
  • Enferm Infecc Microbiol Clin. 2017 Dec;35(10):645-650. PMID: 27493083.
  • Reumatol Clin. 2017 Jan – Feb;13(1):39-41. PMID: 26826910.

Lineas de Investigación

01. Infección por el VIH.

02. Otras infecciones de transmisión sexual.

03. Infecciones endovascular y bacteriemias

04. Infecciones osteoarticulares.



Estudios Clínicos

Temocilina vs Meropenem para el Tratamiento de la Bacteriemia por Enterobacteriales Resistentes a Cefalosporinas de Tercera Generación: Ensayo Aleatorizado y Pragmático..

FUNDACION PUBLICA ANDALUZA PARA LA GESTION DE LA INVESTIGACIÓN EN SALUD DE SEVILLA FISEVI
Fase: III Ensayo Clínico Comercial

CDC-Ensayo clínico fase I/II multicéntrico, aleatorizado y controlado para evaluar la eficacia del tratamiento con plasma hiperinmune obtenido de donantes convalecientes de la infección por COVID-19.

FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD
Fase: I Ensayo Clínico Comercial

“CDC-PREVENCION DE ENFERMEDAD POR SARS-CoV-2 (COVID-19) MEDIANTE LA PROFILAXIS PRE-EXPOSICIÓN DE EMTRICITABINA/TENOFOVIR DISOPROXILO E HIDROXICLOROQUINA EN PERSONAL SANITARIO: ENSAYO CLÍNICO ALEATORIZADO, CONTROLADO CON PLACEBO”.

Plan Nacional Sobre Sida
Fase: III Ensayo Clínico Comercial

CDC-Un ensayo aleatorizado internacional para evaluar tratamientos no licenciados para COVID-19 en pacientes hospitalizados que reciben el tratamiento convencional para COVID que se ofrece en cada hospital. SOLIDARITY.

FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL CLINICO SAN CARLOS INSTITUTO DE INVESTIGACION SANITARIA SAN CARLOS
Fase: III Ensayo Clínico Comercial

Estudio clínico de fase 3, aleatorizado, doble ciego y comparativo con tratamiento activo para evaluar la actividad antirretroviral, la seguridad y la tolerabilidad de doravirina/islatravir una vez al día en participantes infectados por el VIH-1 sin tra.

MERCK SHARP & DOHME DE ESPAÑA SA
Fase: III Ensayo Clínico Comercial

Estudio clínico de fase 3, aleatorizado, doble ciego y controlado con producto activo para evaluar el cambio a doravirina/islatravir (DOR/ISL) una vez al día en participantes con supresión virológica del VIH-1 con bictegravir/emtricitabina/tenofovir a.

MERCK SHARP & DOHME DE ESPAÑA SA
Fase: III Ensayo Clínico Comercial

201636. Estudio Fase III aleatorizado, multicéntrico, de grupos paralelos, de no inferioridad, para evaluar la eficacia, seguridad y tolerabilidad del cambio de una terapia antirretroviral basada en INI, ITINN o IP a dolutegravir más rilpivirina en pacientes adul

LABORATORIOS VIIV HEALTHCARE S.L.
Fase: III ENSAYO CLINICO COMERCIAL

SYMTRI. SYMTRI Study: Ensayo clínico abierto, aleatorizado y multicéntrico para comparar la eficacia, seguridad y tolerabilidad de una pauta de tratamiento TAF/FTC/DRV/cobi vs. ABC/3TC/DTG en pacientes infectados por el VIH-1 naïve de tratamiento antirretroviral.

RED DE INVESTIGACIÓN EN SIDA
Fase: IV ENSAYO CLINICO INDEPENDIENTE

GS-US-311-1717.

Estudio de fase 3b, aleatorizado, doble ciego, con cambio de tratamiento para evaluar F/TAF, en pacientes con infección por VIH-1 y supresión virológica que reciben tratamientos que contienen ABC/3TC

GILEAD SCIENCES, INC
Fase: IIIb ENSAYO CLINICO COMERCIAL

GS-US-380-1878.

Estudio fase III, aleatorizado y abierto para evaluar la seguridad y eficacia del cambio de un régimen formado por atazanavir o darunavir reforzados más emtricitabina/tenofovir o abacavir/lamivudina a GS 9883/emtricitabina/tenofovir alafenamida en adultos

GILEAD SCIENCES, INC
Fase: III ENSAYO CLINICO COMERCIAL

GS-US-380-1490.

Estudio de fase 3, aleatorizado y doble ciego para evaluar la seguridad y la eficacia de GS-9883/emtricitabina/tenofovir alefenamida en comparación con dolutegravir + emtricitabina/tenofovir alefenamida en adultos infectados por el VIH-1 sin tratamiento a

GILEAD SCIENCES, INC
Fase: III ENSAYO CLINICO COMERCIAL

204862. Estudio de fase III, aleatorizado, multicéntrico, con grupos paralelos y de ausencia de inferioridad para evaluar la eficacia, la seguridad y la tolerabilidad del cambio a dolutegravir más lamivudina en adultos infectados por el VIH 1 con supresión viroló

VIIV HEALTHCARE UK LIMITED
Fase: III ENSAYO CLINICO COMERCIAL

Publicaciones científicas

  • Todo
  • D1
  • Q1
  • Q2
  • Otro


A Contemporary Picture of Enterococcal Endocarditis

Pericàs JM, Llopis J, Muñoz P, Gálvez-Acebal J, Kestler M, Valerio M, Hernández-Meneses M, Goenaga MÁ, Cobo-Belaustegui M, Montejo M, Ojeda-Burgos G, Sousa-Regueiro MD, de Alarcón A, Ramos-Martínez A, Miró JM; GAMES Investigators
J Am Coll Cardiol 2020 Feb 11;75(5):482-494


Factors associated with the number of drugs in darunavir/cobicistat regimens

Martinez E, Negredo E, Knobel H, Ocampo A, Sanz J, Garcia-Fraile L, Martin-Carbonero L, Lozano F, Gonzalez-Domenech CM, Gutierrez M, Montero M, Boix V, Payeras A, Torralba M, Gonzalez-Cordon A, Moreno A, Alejos B, Perez-Elias MJ; GeSIDA 9316 CODAR Study Group
J Antimicrob Chemother 2020 Jan 1;75(1):208-214


Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals

Corma-Gómez A, Macías J, Téllez F, Freyre-Carrillo C, Morano L, Rivero-Juárez A, Ríos MJ, Alados JC, Vera-Méndez FJ, Merchante N, Palacios R, Granados R, Merino D, De Los Santos I, Pineda JA
Clin Infect Dis 2020 Dec 3;71(9):2354-2362


GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000-2016)

Aguilera A, Trastoy R, Rodríguez-Frias F, Muñoz-Bellido JL, Melón S, Suárez A, Orduña A, Viciana I, Bernal S, García-Bujalance S, Montiel N, Molina JM, Basaras M, Fernández-Cuenca F, García-Arata I, Reina G, Ocete MD, Fuentes A, Navarro-de la Cruz D, Nieto L, Blazquez de Castro A, Buti M, Álvarez M, García F
J Infect 2020 Oct;81(4):600-606


Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients

Merchante N, Rodríguez-Fernández M, Figueruela B, Rodríguez-Arrondo F, Revollo B, Ibarra S, Téllez F, Merino E, Montero-Alonso M, Galindo MJ, Rivero-Juárez A, Santos IL, Delgado-Fernández M, García-Deltoro M, Vera-Méndez FJ, García MA, Aguirrebengoa K, Portu J, Ríos-Villegas MJ, Villalobos M, Alemán-Valls MR, Mínguez C, Galera C, Macías J, Pineda JA; GEHEP-002 Study Group
AIDS 2020 Aug 1;34(10):1497-1507


Prognostic assessment of valvular surgery in active infective endocarditis: multicentric nationwide validation of a new score developed from a meta-analysis

Varela Barca L, Fernández-Felix BM, Navas Elorza E, Mestres CA, Muñoz P, Cuerpo-Caballero G, Rodríguez-Abella H, Montejo-Baranda M, Rodríguez-Álvarez R, Gutiérrez Díez F, Goenaga MA, Quintana E, Ojeda-Burgos G, de Alarcón A, Vidal-Bonet L, Centella Hernández T, López-Menéndez J; Spanish Collaboration on Endocarditis—Grupo de Apoyo al Manejo de la Endocarditis infecciosa en ESpaña (GAMES)
Eur J Cardiothorac Surg 2020 Apr 1;57(4):724-731


Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study

Ramos-Martínez A, Pericàs JM, Fernández-Cruz A, Muñoz P, Valerio M, Kestler M, Montejo M, Fariñas MC, Sousa D, Domínguez F, Ojeda-Burgos G, Plata A, Vidal L, Miró JM; Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES)
PLoS One 2020 Aug 3;15(8):e0237011


Genetic variants in the LPL and GPIHBP1 genes, in patients with severe hypertriglyceridaemia, detected with high resolution melting analysis

Ariza MJ, Pérez-López C, Almagro F, Sánchez-Tévar AM, Muñiz-Grijalvo O, Álvarez-Sala Walter LA, Rioja J, Sánchez-Chaparro MÁ, Valdivielso P
Clin Chim Acta 2020 Jan;500:163-171


Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project

Palacios-Baena ZR, Valiente de Santis L, Maldonado N, Rosso-Fernández CM, Borreguero I, Herrero-Rodríguez C, López-Cárdenas S, Martínez-Marcos FJ, Martín-Aspas A, Jiménez-Aguilar P, Castón JJ, Anguita-Santos F, Ojeda-Burgos G, Aznarte-Padial MP, Praena-Segovia J, Corzo-Delgado JE, Esteban-Moreno MÁ, Rodríguez-Baño J, Retamar P
BMJ Open 2020 Jul 31;10(7):e035460


Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals

Rivero-Juárez A, Guijo-Rubio D, Tellez F, Palacios R, Merino D, Macías J, Fernández JC, Gutiérrez PA, Rivero A, Hervás-Martínez C
PLoS One 2020 Jan 10;15(1):e0227188


Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis

Hidalgo-Tenorio C, Gálvez J, Martínez-Marcos FJ, Plata-Ciezar A, De La Torre-Lima J, López-Cortés LE, Noureddine M, Reguera JM, Vinuesa D, García MV, Ojeda G, Luque R, Lomas JM, Lepe JA, de Alarcón A
BMC Infect Dis 2020 Feb 21;20(1):160


High Prevalence of Sequences Included in Transmission Clusters Within Newly Diagnosed HIV-1 Patients in Southern Spain (2004-2015)

González-Domenech CM, Sena-Corrales G, Viciana-Ramos I, Palacios-Muñoz R, Mora-Navas L, Clavijo-Frutos E, Santos-González J
Microb Drug Resist 2020 Sep;26(9):1090-1097


Risk of cardiovascular disease in patients with HIV infection undergoing antiretroviral therapy

Estrada V, Domingo P, Suarez-Lozano I, Gutiérrez F, Knobel H, Palacios R, Antela A, Blanco JR, Refoyo E
Rev Clin Esp (Barc) 2020 Apr;220(3):149-154


What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis

Skaathun B, Borquez A, Rivero-Juarez A, Mehta SR, Tellez F, Castaño-Carracedo M, Merino D, Palacios R, Macías J, Rivero A, Martin NK
BMC Infect Dis 2020 Aug 8;20(1):588


Maintenance of virologic suppression and improvement in comorbidities after simplification to raltegravir plus boosted darunavir among treatment-experienced HIV-infected patients

Casado JL, Vizcarra P, Blanco JL, Montejano R, Negredo E, Espinosa N, Montero M, Mena A, Palacios R, Lopez JC, Vergas J, Galindo MJ, Cabello A, Deltoro MG, Diaz De Santiago A; BIRDi study group
Int J STD AIDS 2020 Apr;31(5):467-473


Towards the elimination of hepatitis C: implementation of reflex testing in Andalusia

Casas MP, García F, Freyre-Carrillo C, Montiel N, de la Iglesia A, Viciana I, Domínguez A, Guillot V, Muñoz A, Cantudo P, Franco-Álvarez F, Reguera JA, Romera MA, Cabezas T, Vargas J, Ramírez-Arcos M, Guerrero I, García-Navarrete Á, Pérez-Santos MJ, Clavijo E, Roldán C, Guzmán A, Palanca M, Torres E, Serrano MDC, Lozano MDC, Becerril B, Luzón P, Galán MÁ, Alados JC, García F
Rev Esp Enferm Dig 2020 Jul;112(7):515-519

  1. Real, LM, Fernández-Fuertes, M, Sáez, ME, Rivero-Juárez, A, Frías, M, Téllez, F et al.. A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study). Liver Int. 2019;39 (10):1918-1926. doi: 10.1111/liv.14177. PubMed PMID:31206233 .
Search PubMed
  1. Pérez-Molina, JA, Martínez, E, Blasco, AJ, Arribas, JR, Domingo, P, Iribarren, JA et al.. Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults. Enferm Infecc Microbiol Clin (Engl Ed). 2019;37 (3):151-159. doi: 10.1016/j.eimc.2018.04.010. PubMed PMID:29884455 .
Search PubMed
  1. Hidalgo-Tenorio, C, Cortés, LL, Gutiérrez, A, Santos, J, Omar, M, Gálvez, C et al.. DOLAMA study: Effectiveness, safety and pharmacoeconomic analysis of dual therapy with dolutegravir and lamivudine in virologically suppressed HIV-1 patients. Medicine (Baltimore). 2019;98 (32):e16813. doi: 10.1097/MD.0000000000016813. PubMed PMID:31393412 PubMed Central PMC6708975.
Search PubMed
  1. Jarrin, I, Suarez-Garcia, I, Moreno, C, Tasias, M, Del Romero, J, Palacios, R et al.. Durability of first-line antiretroviral regimens in the era of integrase inhibitors: a cohort of HIV-positive individuals in Spain, 2014-2015. Antivir Ther. 2019;24 (3):167-175. doi: 10.3851/IMP3297. PubMed PMID:30747107 .
Search PubMed
  1. Macías, J, Téllez, F, Rivero-Juárez, A, Palacios, R, Morano, LE, Merino, D et al.. Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients. J Viral Hepat. 2019;26 (1):48-54. doi: 10.1111/jvh.13003. PubMed PMID:30199593 .
Search PubMed
  1. Pasquau, J, de Jesus, SE, Arazo, P, Crusells, MJ, Ríos, MJ, Lozano, F et al.. Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study). BMC Infect Dis. 2019;19 (1):207. doi: 10.1186/s12879-019-3817-6. PubMed PMID:30819101 PubMed Central PMC6396540.
Search PubMed
  1. Frías, M, Rivero-Juárez, A, Téllez, F, Palacios, R, Jiménez-Arranz, Á, Pineda, JA et al.. Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR. Sci Rep. 2019;9 (1):12507. doi: 10.1038/s41598-019-48966-9. PubMed PMID:31467339 PubMed Central PMC6715682.
Search PubMed
  1. Panel of Experts from the Metabolic Disorders and Comorbilities Study Group (GEAM), Aids Study Group (GeSIDA), National Aids Plan (PNS). Electronic address: rpolor@msssi.es. Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection. Enferm Infecc Microbiol Clin (Engl Ed). 2019;37 (1):50-55. doi: 10.1016/j.eimc.2017.06.007. PubMed PMID:28823613 .
Search PubMed
  1. AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Executive summary of the GeSIDA consensus document on control and monitoring of HIV-infected patients. Enferm Infecc Microbiol Clin (Engl Ed). ;37 (7):467-475. doi: 10.1016/j.eimc.2018.03.011. PubMed PMID:29793873 .
Search PubMed
  1. Jiménez Villodres, M, García Gutiérrez, G, García Frías, P, Rioja Villodres, J, Martín Velázquez, M, Sánchez Chaparro, MÁ et al.. Fractional excretion of phosphorus and vascular calcification in stage 3 chronic kidney disease. J Investig Med. 2019;67 (3):674-680. doi: 10.1136/jim-2018-000852. PubMed PMID:30429202 .
Search PubMed
  1. Corma-Gómez, A, Morano, L, Téllez, F, Rivero-Juárez, A, Real, LM, Alados, JC et al.. HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals. AIDS. 2019;33 (7):1167-1174. doi: 10.1097/QAD.0000000000002186. PubMed PMID:30845068 .
Search PubMed
  1. Resino, S, Navarrete-Muñoz, MA, Blanco, J, Pacheco, YM, Castro, I, Berenguer, J et al.. IL7RA rs6897932 Polymorphism is Associated with Better CD4+ T-Cell Recovery in HIV Infected Patients Starting Combination Antiretroviral Therapy. Biomolecules. 2019;9 (6):. doi: 10.3390/biom9060233. PubMed PMID:31208153 PubMed Central PMC6627042.
Search PubMed
  1. Ivanova-Georgieva, R, Ruiz-Morales, J, García-Cabrera, E, García-López, MV, Gálvez-Acebal, J, Plata-Ciezar, A et al.. Left-sided infective endocarditis caused by Streptococcus agalactiae: rare and serious. Eur J Clin Microbiol Infect Dis. 2019;38 (2):265-275. doi: 10.1007/s10096-018-3423-3. PubMed PMID:30430377 .
Search PubMed
  1. Domingo, P, Suarez-Lozano, I, Gutierrez, F, Estrada, V, Knobel, H, Palacios, R et al.. Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study. Nefrologia (Engl Ed). ;39 (5):497-505. doi: 10.1016/j.nefro.2019.01.009. PubMed PMID:31027896 .
Search PubMed
  1. Saludes, V, Antuori, A, Reinhardt, B, Viciana, I, Clavijo, E, Schreiber, L et al.. Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay. Sci Rep. 2019;9 (1):3678. doi: 10.1038/s41598-019-40099-3. PubMed PMID:30842623 PubMed Central PMC6403303.
Search PubMed
  1. Macías, J, Morano, LE, Téllez, F, Granados, R, Rivero-Juárez, A, Palacios, R et al.. Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy. J Hepatol. 2019;71 (1):45-51. doi: 10.1016/j.jhep.2019.02.018. PubMed PMID:30853642 .
Search PubMed
  1. de la Cruz Cosme, C, Dawid Milner, MS, Ojeda Burgos, G, Gallardo Tur, A, Márquez Martínez, M, Segura, T et al.. Validation of a basic neurosonology laboratory for detecting cervical carotid artery stenosis. Neurologia (Engl Ed). ;34 (6):367-375. doi: 10.1016/j.nrl.2017.01.015. PubMed PMID:28347575 .
Search PubMed
  1. Saludes, V, Antuori, A, Reinhardt, B, Viciana, I, Clavijo, E, Schreiber, L et al.. Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay. Sci Rep. 2019;9 (1):3678. doi: 10.1038/s41598-019-40099-3. PubMed PMID:30842623 PubMed Central PMC6403303.
Search PubMed
  1. Macías, J, Morano, LE, Téllez, F, Granados, R, Rivero-Juárez, A, Palacios, R et al.. Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy. J Hepatol. 2019;71 (1):45-51. doi: 10.1016/j.jhep.2019.02.018. PubMed PMID:30853642 .
Search PubMed
  1. de la Cruz Cosme, C, Dawid Milner, MS, Ojeda Burgos, G, Gallardo Tur, A, Márquez Martínez, M, Segura, T et al.. Validation of a basic neurosonology laboratory for detecting cervical carotid artery stenosis. Neurologia (Engl Ed). ;34 (6):367-375. doi: 10.1016/j.nrl.2017.01.015. PubMed PMID:28347575 .
Search PubMed
  1. AIDS Study Group (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology and the National AIDS Plan. Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2017). Enferm Infecc Microbiol Clin (Engl Ed). ;36 (7):435-445. doi: 10.1016/j.eimc.2017.04.001. PubMed PMID:28579016 .
Search PubMed
  1. Benito, JM, Hillung, J, Restrepo, C, Cuevas, JM, León, A, Ruiz-Mateos, E et al.. Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients. Int J Med Sci. 2018;15 (2):95-100. doi: 10.7150/ijms.22317. PubMed PMID:29333092 PubMed Central PMC5765721.
Search PubMed
  1. Gómez Ayerbe, C, Santos González, J, Palacios Muñoz, R. Symtuza® (DRV/c/FTC/TAF) in the management of treatment-naive HIV-patients. Enferm Infecc Microbiol Clin (Engl Ed). 2018;36 Suppl 2 :17-21. doi: 10.1016/S0213-005X(18)30393-8. PubMed PMID:30545467 .
Search PubMed
  1. Goenaga Sánchez, MÁ, Kortajarena Urkola, X, Bouza Santiago, E, Muñoz García, P, Verde Moreno, E, Fariñas Álvarez, MC et al.. Aetiology of renal failure in patients with infective endocarditis. The role of antibiotics. Med Clin (Barc). 2017;149 (8):331-338. doi: 10.1016/j.medcli.2017.03.009. PubMed PMID:28431897 .
Search PubMed
  1. Kestler, M, Muñoz, P, Marín, M, Goenaga, MA, Idígoras Viedma, P, de Alarcón, A et al.. Endocarditis caused by anaerobic bacteria. Anaerobe. 2017;47 :33-38. doi: 10.1016/j.anaerobe.2017.04.002. PubMed PMID:28389412 .
Search PubMed
  1. Becerra-Muñoz, VM, Ruíz-Morales, J, Rodríguez-Bailón, I, Sánchez-Espín, G, López-Garrido, MA, Robledo-Carmona, J et al.. Infective endocarditis in patients with bicuspid aortic valve: Clinical characteristics, complications, and prognosis. Enferm Infecc Microbiol Clin. 2017;35 (10):645-650. doi: 10.1016/j.eimc.2016.06.017. PubMed PMID:27493083 .
Search PubMed
  1. Viciana, I, González-Domenech, CM, Palacios, R, Delgado, M, Del Arco, A, Tellez, F et al.. Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain. J Antimicrob Chemother. 2016;71 (2):357-61. doi: 10.1093/jac/dkv332. PubMed PMID:26483513 .
Search PubMed
  1. Teófilo, E, Rocha-Pereira, N, Kuhlmann, B, Antela, A, Knechten, H, Santos, J et al.. Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study. HIV Clin Trials. 2016;17 (1):17-28. doi: 10.1080/15284336.2015.1112494. PubMed PMID:26899539 PubMed Central PMC4975100.
Search PubMed
  1. Riera, M, Esteban, H, Suarez, I, Palacios, R, Lozano, F, Blanco, JR et al.. [Validation and adhesion to GESIDA quality indicators in patients with HIV infection]. Enferm Infecc Microbiol Clin. ;34 (6):346-52. doi: 10.1016/j.eimc.2015.09.003. PubMed PMID:26530224 .
Search PubMed
  1. Estrada, V, Bernardino, JI, Masiá, M, Iribarren, JA, Ortega, A, Lozano, F et al.. Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain. HIV Clin Trials. ;16 (2):57-65. doi: 10.1179/1528433614Z.0000000008. PubMed PMID:25874992 .
Search PubMed
  1. Rivero-Juarez, A, Gutierrez-Valencia, A, Castaño, M, Merino, D, Neukam, K, Ríos-Villegas, MJ et al.. Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain. Eur J Clin Microbiol Infect Dis. 2015;34 (11):2247-55. doi: 10.1007/s10096-015-2476-9. PubMed PMID:26342330 PubMed Central PMC4607719.
Search PubMed
  1. Mira, JA, Neukam, K, López-Cortés, LF, Rivero-Juárez, A, Téllez, F, Girón-González, JA et al.. Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia. Eur J Clin Microbiol Infect Dis. 2015;34 (9):1879-84. doi: 10.1007/s10096-015-2426-6. PubMed PMID:26115631 .
Search PubMed
  1. Panel of experts from the Metabolic Disorders Study Group (GEAM), National Aids Plan (SPNS), Aids Study Group (GeSIDA), Polo Rodríguez, R, Galindo Puerto, MJ, Dueñas, C, Gómez Candela, C, Estrada, V et al.. Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection. Enferm Infecc Microbiol Clin. 2015;33 (1):41-7. doi: 10.1016/j.eimc.2014.05.018. PubMed PMID:25096166 .
Search PubMed
  1. Expert Panel of GESIDA and the National AIDS Plan, Berenguer, J, Polo, R, Aldeguer, JL, Lozano, F, Aguirrebengoa, K et al.. Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015). Enferm Infecc Microbiol Clin. 2015;33 (8):544-56. doi: 10.1016/j.eimc.2015.03.017. PubMed PMID:26021186 .
Search PubMed
  1. Macías, J, López-Cortés, LF, Téllez, F, Recio, E, Ojeda-Burgos, G, Ríos, MJ et al.. Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection. PLoS One. 2015;10 (12):e0143492. doi: 10.1371/journal.pone.0143492. PubMed PMID:26640956 PubMed Central PMC4671604.
Search PubMed
  1. Merchante, N, Téllez, F, Rivero-Juárez, A, Ríos-Villegas, MJ, Merino, D, Márquez-Solero, M et al.. Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis. BMC Infect Dis. 2015;15 :557. doi: 10.1186/s12879-015-1291-3. PubMed PMID:26643257 PubMed Central PMC4672550.
Search PubMed
  1. López-Calderón, C, Palacios, R, Cobo, A, Nuño, E, Ruiz, J, Márquez, M et al.. Serum ferritin in HIV-positive patients is related to immune deficiency and inflammatory activity. Int J STD AIDS. 2015;26 (6):393-7. doi: 10.1177/0956462414539669. PubMed PMID:24912540 .
Search PubMed
  1. González-Domenech, CM, Antequera Martín-Portugués, I, Clavijo-Frutos, E, Márquez-Solero, M, Santos-González, J, Palacios-Muñoz, R et al.. [Syphilis and human immunodeficiency virus infection: an endemic infection in men who have sex with men]. Enferm Infecc Microbiol Clin. 2015;33 (1):32-6. doi: 10.1016/j.eimc.2014.07.013. PubMed PMID:25444048 .
Search PubMed

Consulta el histórico de Newsletter:

Calle Doctor Miguel Díaz Recio , 28 Málaga 29010

(+34) 951 440 260
Fax: (+34) 951 440 263